Biographical Sketch
Dr. Thomas Callahan is a physician in the Electrophysiology Section of the Sydell and Arnold Miller Family Heart & Vascular Institute at Cleveland Clinic. His office is located on the main campus. He came to the Cleveland Clinic in 2003 as a Fellow in Cardiovascular Medicine and subsequently also completed a Fellowship in Cardiac Electrophysiology and Pacing. He is board certified in Clinical Cardiac Electrophysiology, Cardiovascular Disease,Internal Medicine, and Nuclear Cardiology. His specialty areas include: atrial and ventricular arrhythmias including atrial fibrillation and catheter ablation for treatment of these arrhythmias including pulmonary vein isolation. He also specializes in device therapy including device and lead extraction and the implantation of pacemakers, implantable defibrillators (ICDs), and biventricular pacemakers and ICDs.
Dr. Callahan is a graduate of Ohio's Oberlin College. He received a Master's Degree from the University of Michigan, and then continued his education, earning a medical degree from Eastern Virginia Medical School, Norfolk, VA. Prior to joining the Cleveland Clinic, Dr. Callahan served as resident and then chief resident in Internal Medicine at the Hospital of the University of Pennsylvania. He has received several honors and awards, including the Dawson Award for Clinical Excellence and Humanism.
Dr. Callahan has conducted research in his areas of specialization that has been published in leading medical journals. He is a member of the Heart Rhythm Society, American College of Cardiology, and the American Medical Association.
Specialty Interests
arrhythmias, atrial fibrillation, catheter ablation, pulmonary vein isolation, device therapy for heart failure, pacemaker, implantable defibrillator (ICD), lead extraction (pacemaker/ICD)
Industry Relationships
Cleveland Clinic physicians and scientists may collaborate with
the pharmaceutical or medical device industries to help develop
medical breakthroughs or provide medical education about recent
trends. The collaborations are reviewed as part of the Cleveland
Clinic’s procedures. The Cleveland Clinic publicly discloses
payments to its physicians and scientists for speaking and
consulting of $5,000 or more per year, and any equity,
royalties, and fiduciary relationships in companies with which
they collaborate. The Cleveland Clinic requires its doctors
to approve the public disclosures of their scientific
collaborations with industry. As of 10/24/2008 the review
process regarding Dr. Callahan, IV’s disclosure had not been
completed. Patients should feel free to contact their doctor
about any of the relationships and how the relationships are
overseen by the Cleveland Clinic. To learn more about the
Cleveland Clinic’s policies on collaborations with industry
and innovation management, go to our
Integrity in Innovation page.
